PGEN.NASDAQPrecigen, INC

Form 4: Precigen Director Nancy Agee Acquires Shares and Stock Options

Sentiment:

SEC Form 4 Filing


Director Nancy Agee received shares and stock options from Precigen, Inc. on July 5, 2024.

Summary

  • On July 5, 2024, Nancy H. Agee, a director of Precigen, Inc., acquired 17,605 shares of common stock at a price of $1.42 per share in lieu of a pro-rated annual retainer of $24,999.
  • Agee also acquired 126,760 restricted stock units (RSUs), which vest in full on July 5, 2025, and represent a contingent right to receive one share of Precigen common stock each.
  • Additionally, Agee acquired options to purchase 147,540 shares of common stock at an exercise price of $1.42, vesting in four equal installments annually starting July 5, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine compensation and equity grants to a director. It doesn't inherently indicate positive or negative performance.

Positives

  • The acquisition of shares and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The RSUs vest in full on July 5, 2025, and the options vest in four equal installments of 25% on each of July 5, 2025, July 5, 2026, July 5, 2027 and July 5, 2028.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and equity ownership of company directors.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of director confidence in the company.

Key Dates

DateDescription
07/05/2024Date of transaction: Acquisition of common stock, RSUs, and stock options.
07/05/2025RSUs vest in full.
07/05/2025First vesting date for stock options (25%).
07/05/2026Second vesting date for stock options (25%).
07/05/2027Third vesting date for stock options (25%).
07/05/2028Fourth vesting date for stock options (25%).
07/05/2034Expiration date for stock options.
07/09/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.